Treatments | 1Effects | ||||||||
(g/100g FA) | T0 2 | Latin square3 | SEM4 | T | S | P | P*T | ||
T-1 | T-2 | T-3 | |||||||
C4:0 | 1.92 | 2.14 | 2.13^ | 2.20^ | 0.073 | 0.75 | 0.43 | 0.00 | 0.04 |
C6:0 | 1.70 | 1.81 | 1.84^ | 1.77 | 0.04 | 0.38 | 0.17 | 0.01 | 0.59 |
C8:0 | 1.19 | 1.28ª | 1.31a^ | 1.19b | 0.04 | 0.02 | 0.26 | 0.11 | 0.75 |
C10:0 | 3.07 | 3.27ª | 3.32a | 3.00b | 0.16 | 0.01 | 0.47 | 0.12 | 0.35 |
C10:1 | 0.29 | 0.33^ | 0.34* | 0.33^ | 0.02 | 0.67 | 0.71 | 0.24 | 0.26 |
C12:0 | 3.87 | 4.00a | 4.02a | 3.68b | 0.23 | 0.04 | 0.61 | 0.01 | 0.37 |
C12:1 | 0.08 | 0.093b** | 0.102a** | 0.107a** | 0.00 | 0.01 | 0.62 | 0.01 | 0.13 |
C14:0 | 11.61 | 12.00^ | 12.14** | 11.96 | 0.33 | 0.74 | 0.84 | 0.36 | 0.10 |
C14:1 | 0.94 | 1.02 | 1.11 | 1.02 | 0.14 | 0.75 | 0.69 | 0.73 | 0.39 |
C15:0 | 1.56 | 1.29* | 1.22** | 1.28** | 0.07 | 0.40 | 0.68 | 0.01 | 0.22 |
Iso-C15:0 | 0.42 | 0.37 | 0.29 | 0.51 | 0.08 | 0.22 | 0.49 | 0.51 | 0.36 |
C15:1 | 0.21 | 0.224b^ | 0.253a** | 0.261a** | 0.01 | <0.01 | 0.57 | 0.01 | 0.27 |
C16:0 | 28.27 | 29.98^ | 29.85 | 29.33 | 1.27 | 0.71 | 0.61 | 0.67 | 0.45 |
C16:1 | 1.29 | 1.39 | 1.38 | 1.42 | 0.08 | 0.79 | 0.33 | 0.96 | 0.04 |
C17:0 | 0.63 | 0.543a** | 0.510b** | 0.506b** | 0.02 | 0.06 | 0.28 | 0.33 | 0.70 |
C17:1 | 0.22 | 0.20ab^ | 0.19b* | 0.21a | 0.01 | 0.02 | 0.56 | 0.01 | 0.01 |
C18:0 | 10.62 | 9.43^ | 10.10 | 10.51 | 0.65 | 0.18 | 0.91 | 0.43 | 0.10 |
trans-9 C18:1 (elaidic) | 0.49 | 0.36 | 0.26** | 0.28* | 0.03 | 0.12 | 0.31 | 0.11 | 0.62 |
trans-10 C18:1 | 1.23 | 0.783ª | 0.552b^ | 0.382c* | 0.05 | <0.01 | 0.28 | 0.05 | 0.34 |
trans-11 C18:1 (vaccenic. VA) | 1.45 | 1.84c** | 2.17b* | 2.77a** | 0.10 | <0.01 | 0.03 | 0.01 | 0.04 |
cis-9 C18:1 (oleic) | 21.69 | 20.06* | 20.19* | 21.16 | 1.00 | 0.20 | 0.49 | 0.82 | 0.46 |
cis-11 C18:1 | 1.07 | 0.91* | 0.84** | 0.84** | 0.04 | 0.17 | 0.18 | 0.00 | 0.20 |
cis-9, cis-12 C18:2 (linoleic) | 4.17 | 4.18ª | 3.35b** | 2.47c** | 0.17 | <0.01 | 0.38 | 0.00 | 0.22 |
C18:3 (linolenic) | 0.32 | 0.51b** | 0.57b** | 0.67a** | 0.25 | <0.01 | 0.03 | 0.57 | 0.63 |
cis-9,trans-11 C18:2 (CLA) | 1.07 | 1.23b* | 1.29b | 1.54a** | 0.05 | <0.01 | 0.03 | 0.00 | 0.10 |
Total CLA | 1.12 | 1.29b* | 1.35b | 1.59a** | 0.05 | <0.01 | 0.04 | <0.01 | 0.11 |
C20:4 | 0.199 | 0.219ª | 0.182b* | 0.166b** | 0.01 | <0.01 | 0.65 | 0.58 | 0.82 |
C20:5 (EPA) | 0.034 | 0.041b | 0.047b** | 0.059a** | 0.00 | <0.01 | 0.67 | 0.40 | 0.31 |
C22:6 (DHA) | 0.019 | 0.021 | 0.020 | 0.019 | 0.002 | 0.69 | 0.41 | 0.35 | 0.26 |
TOTAL FA | 99.66 | 99.58 | 99.63 | 99.70 | 0.04 | 0.23 | 0.64 | 0.48 | 0.86 |
De novo FA (C4:0-C15:1) | 26.84 | 27.83 | 28.07 | 27.30 | 0.72 | 0.31 | 0.58 | 0.33 | 0.19 |